Rajiv R Ratan

USPTO Granted Patents = 16 (Patent Applications = 4)

EPO Patents = 2 (Patent Applications = 5)

Average Co-Inventor Count = 2.4

ph-index = 1

Forward Citations = 9(Granted Patents)

Location History:

Southborough, MA (US) (2010)
Cambridge, MA (US) (2014)
Scarsdale, NY (US) (2012 - 2024)

Company Filing History:

6 out of 8

Burke Neurological Institute

The City University of New York

patents

5. 3 out of 1,521

Cornell Research Foundation Inc.

patents

6. 2 out of 517

Beth Israel Deaconess Medical Center, Inc.

patents

7. 1 out of 204

University of Vermont and State Agricultural College

patents

where one patent can have more than one assignee

Years Active: 2010-2025

Loading Chart...

16 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 12414929 - Methods of treating brain disorders (2025-09-16),

2. 12090130 - Methods of treating brain disorders (2024-09-17),

3. 11963939 - Use of N-acetylcysteine to treat central nervous system disorders (2024-04-23),

4. 11878997 - Methods of treatment comprising Selenoprotein P fragment-containing compounds (2024-01-23),

5. 11660278 - Use of N-acetylcysteine to treat central nervous system disorders (2023-05-30),

6. 11078236 - Selenium-based therapies (2021-08-03),

7. 10716783 - Prolylhydroxylase/ATF4 inhibitors and methods of use for treating neural cell injury or death and conditions resulting therefrom (2020-07-21),

8. 9795587 - Compounds for enhancing hypoxia inducible factor activity and methods of use (2017-10-24),

9. 9505741 - Prolylhydroxylase inhibitors and methods of use (2016-11-29),

10. 9345694 - Compounds for enhancing arginase activity and methods of using same (2016-05-24),

11. 9200046 - Reporter system for high throughput screening of compounds and uses thereof (2015-12-01),

12. 9034299 - ATF4 inhibitors and their use for neural protection, repair, regeneration, and plasticity (2015-05-19),

13. 9029322 - Compounds for enhancing p21 expression and methods of use thereof (2015-05-12),

14. 8673594 - Methods for stimulating nervous system regeneration and repair by regulating arginase I and polyamine synthesis (2014-03-18),

15. 8168749 - Stimulating neurite outgrowth using Tctex-1-related polypeptides (2012-05-01),

Title: The Innovative Contributions of Rajiv R Ratan

Introduction

Rajiv R Ratan is a prominent inventor based in Scarsdale, NY, whose innovative work has resulted in a remarkable portfolio of 15 patents. His contributions primarily focus on advancing medical treatments, particularly for brain disorders, using cutting-edge methodologies.

Latest Patents

Among his latest patents, Rajiv Ratan has developed methods of treating brain disorders, specifically detailing the administration of N-acetylcysteine (NAC) through intranasal nose-to-brain delivery. This innovative approach allows for the monitoring of NAC's effects utilizing magnetic resonance spectroscopy (MRS). Additionally, he has contributed to methods for treating central nervous system conditions linked with oxidative stress, employing a 5-lipoxygenase activating protein (FLAP) inhibitor such as N-acetylcysteine or nordihydroguaiaretic acid. Furthermore, his research includes the therapeutic applications of N-acetylcysteine combined with other agents like prostaglandin E2 to target various central nervous system disorders.

Career Highlights

Rajiv Ratan's professional journey includes significant tenures at esteemed institutions such as Cornell University and Burke Neurological Institute. His work has been pivotal in exploring new treatment modalities aimed at enhancing patient outcomes for brain injuries and related conditions.

Collaborations

Throughout his career, Rajiv has collaborated with notable individuals in his field, including Saravanan Karuppagounder and Marie T Filbin. These partnerships have undoubtedly enriched his research and brought additional insight to his innovative projects.

Conclusion

Rajiv R Ratan's dedication to advancing medical science through his inventions illustrates the power of innovation in addressing complex health challenges. His extensive patent portfolio and collaborative efforts mark him as a significant figure in the landscape of neurological research and treatment strategies.

This text is generated by artificial intelligence and may not be accurate.